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Abstract
The 5-year survival rate for oral cavity cancer is poorer than for breast, colon or prostate cancer, and has improved only
slightly in the last three decades. Hence, new therapeutic strategies are urgently needed. Here we demonstrate by tissue
micro array analysis for the first time that RNA-binding protein La is significantly overexpressed in oral squamous cell
carcinoma (SCC). Within this study we therefore addressed the question whether siRNA-mediated depletion of the La
protein may interfere with known tumor-promoting characteristics of head and neck SCC cells. Our studies demonstrate
that the La protein promotes cell proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC
cells. We also reveal that La is required for the expression of b-catenin as well as matrix metalloproteinase type 2 (MMP-2)
within these cells. Taken together these data suggest a so far unknown function of the RNA-binding protein La in
promoting tumor progression of head and neck SCC.
Citation: Sommer G, Rossa C, Chi AC, Neville BW, Heise T (2011) Implication of RNA-Binding Protein La in Proliferation, Migration and Invasion of Lymph Node-
Metastasized Hypopharyngeal SCC Cells. PLoS ONE 6(10): e25402. doi:10.1371/journal.pone.0025402
Editor: Donald Gullberg, University of Bergen, Norway
Received January 18, 2011; Accepted September 2, 2011; Published October 10, 2011
Copyright:  2011 Sommer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Thiswork wassupported bytheDepartment of Biochemistry &MolecularBiology (MUSC), by SC COBREfor OralHealthResearch P20RR017696-09 and NIH/NCRR
1R03DE021729-01. FACS analysis was performed at the Flow Cytometry Shared Resource as part of the Hollings Cancer Center at MUSC, which is funded by a Cancer Center
Support Grant P30 CA138313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sommerg@musc.edu
Introduction
Head and neck (HN) cancer is the sixth most common cancer and
affects more than 500,000 individuals globally [1,2]. This type of
cancer typically occurs in the mucosal lining of head or neck regions,
e.g. esophagus, sinuses, nasal cavity, pharynx, mouth and lips. The
most common type of HN cancer is the oral cavity cancer of which
about 90% are squamous cell carcinomas (SCC) [3]. The 5-year
survival rate for oral cavity cancer is 60%, which is poorer than that of
breast, colon or prostate cancer, and only slightly improved by 5% in
the last three decades [4]. Therefore, novel treatment strategies for
oral SCC are urgently needed. Oral SCC grows locally in an invasive
manner and mainly metastasizes to regional lymph nodes. Typically
50% of oral SCC patients have a detectable lymph node involvement
at presentation. Patients with nodal metastasis have a markedly worse
prognosis for treatment outcome [5]. The risk of regional metastasis is
related to tumor size and depth of infiltration of the primary tumor
[5]. The cellular and molecular mechanisms of tumor progression in
the oral cavity remain poorly understood.
The La protein (La/SSB) is a ubiquitously and predominantly
nuclear expressed RNA-binding protein, which is known to shuttle
between the nucleus and cytoplasm [6,7,8,9]. In mammals La is
essential in early development [10]. La is a 408-amino acid protein
with three RNA-binding surfaces (the La motif, and two RNA
recognition motifs [11]), a nuclear localization sequence, a nuclear
retention signal [12], and a nucleolus localization sequence [13].
Little is known about the regulation of La expression [8,14]. La is
posttranslationally modified by phosphorylation [6,15,16,17] and
sumoylation [18], both suggested regulating its cellular functions.
La is presumed to act as a RNA chaperone to stabilize or refold
RNA structures [19,20]. La is known to promote processing of
tRNA precursors and non-coding RNAs [12]. In addition, La
supports mRNA translation of various cellular mRNAs, like cyclin
D1 [21], XIAP [22] and Mdm2 [23]. Herein we present data
demonstrating that the RNA-binding protein La is overexpressed
in oral SCC tissue, and supports cell proliferation, migration and
invasion of metastasis-derived hypopharyngeal SCC cells in vitro, as
well as protein expression of tumor promoting factors b-catenin
and MMP-2 but not cyclin D1, focal adhesion kinase (FAK) or
cofilin within these cells. Our findings suggest that La may play an
important role in tumor progression of head and neck SCC.
Results and Discussion
The RNA-binding protein La is overexpressed in oral SCC
tissue
Our previous studies revealed that the La protein is overex-
pressed in cervical cancer tissue [21]. To answer the question
whether La is also aberrantly expressed in other types of cancer, we
analyzed an oral cavity tissue microarray (TMA, Imgenex Corp.,
IMT-01250), consisting of 9 unmatched adjacent normal and 42
tumortissue cores,diagnosedasSCC tissue rangingfrom gradesIto
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antibody 3B9 [24] and counterstaining with Hematoxylin clearly
revealed pronounced La-specific nuclear staining of SCC tissue but
not normal epithelium (Fig. 1A). As a control, hybridization with
immunoglobulin isotype IgG 2a, k and counterstaining with
Hematoxylin was performed, and no nonspecific brown staining
was detected (Fig. S1). In addition we verified the specificity of the
monoclonal human La 3B9 antibody by hybridization of siRNA-
depleted UM-SCC 22B cells demonstrating that La-specific knock
down within these cells almost completely abolishes the brown
staining (Fig. S2). The TMA was scored by two pathologists
independently and revealed that the percentage of La-positive cells
was significantly higher in oral SCC tissue compared to normal
epithelial tissue (Fig. 1B). In addition, the intensity of nuclear La
staining was significantly higher in SCC cells compared to normal
cells (Fig. 1C). These data show for the first time that not only more
SCC cells express the La protein, but also that the La levels per cell
were elevated. These data demonstrate that the RNA-binding
protein La is aberrantly overexpressed in oral SCC tissue.
It has been shown that the La protein is overexpressed in a
panel of tumor cell lines [25], chronic myelogenous leukaemia
patients [23], and recently in cervical cancer tissue [21], suggesting
a role of La in cancer pathogenesis. The finding that La stimulates
mRNA translation of cyclin D1 in cervical cancer cells [21] and
Mdm2 in BCR/ABL-transformed myeloid precursor cells [23],
suggests an important role of La in translational control of tumor-
promoting factors in cancerous cells. Although little is known
about the regulation of La in cancerous cells, the finding that
mammalian La is phosphorylated by Casein Kinase 2 [15,16] and
murine La by protein kinase AKT, which induces cytoplasmic
accumulation of La and La-dependent translational activation of a
specific mRNA subset [6], suggests that not only elevated La
expression but also its phosphorylation status and/or intracellular
localization is critical during tumorigenesis. However, our data are
not allowing us to draw any conclusion about the intracellular
localization of La in normal versus tumor cells and more work is
needed to test whether the ratio of nuclear:cytoplasmic La is
changed during tumor initiation or progression within the oral
cavity. In conclusion we demonstrate that the RNA-binding
protein La is significantly overexpressed in oral SCC tissue,
suggesting that La may play a role in tumorigenesis of cancerous
cells originating from various types of tissue [21,23].
The La protein contributes to proliferation and cell cycle
progression of lymph node-metastasized
hypopharyngeal SCC cells
To elucidate whether La affects cellular processes known to
contribute to tumorigenesis of HNSCC cells, we focused on UM-
SCC 22B cells derived from a lymph node metastasis, which
primary tumor site was presented as hypopharyngeal SCC [26]
(from now on referred to as SCC 22B). To exclude a possible
cross-contamination and overgrowth of cell line SCC 22B with
HeLa cells, which were earlier cultured in our laboratory, we
compared light microscopy images of our cultured SCC 22B cells
with images taken from HeLa cells previously purchased from
ATCC (Fig. S3). Morphological differences of the scale-like,
polygonal SCC 22B cells and the rather elongated-shaped cervical
cancer HeLa cells clearly distinguishes the two different cell lines
by light microscopy. To test whether La protein regulates
proliferation in metastasis-derived SCC cells, we reduced La
levels in SCC 22B cells by transfecting La-specific small interfering
RNA (La siRNA) [21] or luciferase-specific siRNA [27] as control
(Con siRNA). Western blot analysis of cell lysates demonstrated
the efficient depletion of La protein in siRNA-treated SCC 22B
cells (Fig. 2A). The re-attachment efficiency was monitored after
Figure 1. RNA-binding protein La is overexpressed in squamous cell carcinoma (SCC) tissue. (A) Human La-specific staining of normal
epithelial and SCC tongue tissue by applying the monoclonal human La-specific 3B9 antibody. Scale bar represents 100 mm. (B) Scoring of oral tissue
microarray (TMA) harboring 9 normal and 42 SCC tissue cores stained with human La-specific 3B9 antibody revealed highly significant overexpression
of nuclear La in oral SCC. Percentage [%] of La-positive cells in normal versus SCC tissue (P value,0.001 (three asterisks)). (C) Intensity of nuclear La-
staining in normal versus SCC tissue (P value,0.05 (one asterisks)). Two-tailed P values were determined by paired t-test applying Prism 4 (GraphPad
Software).
doi:10.1371/journal.pone.0025402.g001
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that the re-attachment of the cells was unchanged despite La
depletion (Fig. 2A). In contrast, the proliferation rate of La-
depleted cells was significantly reduced, demonstrating that cells
with reduced La expression grow about 40% slower compared to
control-treated cells (Fig. 2B). To test whether La depletion
induced cell death, the viability of La-depleted cells was analyzed
by trypan blue exclusion assays (Fig. 2C), FACS analysis of
Annexin V and propidium iodide co-stained cells (Fig. S4) and
analysis of caspase-3-dependent PARP cleavage (Fig. 2D). All tests
clearly demonstrated that the proliferation rate in La-depleted
SCC 22B cells was not reduced by increased cell death, which is in
line with studies previously performed in HeLa cells [21]. Next,
cell cycle analysis of propidium iodide-stained cells by FACS
showed that La depletion induced a G1-arrest in SCC 22B cells
concomitant with a decrease of S- and G2-phase cell populations
(Fig. 2E), suggesting that the proliferation rate was reduced via a
defect in cell cycle progression. Since we have recently shown that
overexpression of La stimulates and depletion of La reduces IRES-
mediated cyclin D1 mRNA translation in cervical cancer HeLa
cells [21], we analyzed whether the expression of the cell cycle
regulator cyclin D1 is reduced in La-depleted SCC 22B cells as
well. Our data clearly demonstrate that cyclin D1 expression in
La-depleted SCC 22B cells is not affected (Fig. 2F). Hence, in
contrast to cervical carcinoma cells in which La contributes to
cyclin D1 expression and cell proliferation [21], La did not
contribute to cyclin D1 expression in SCC 22B cells. Therefore,
our data suggest that La regulates cyclin D1 expression in a tissue-
specific manner. Taken together these data demonstrate that La
expression contributes to cell proliferation and cell cycle
progression of metastasis-derived SCC 22B cells.
La supports SCC 22B cell migration in vitro
To address whether La is involved in tumor progression of SCC
cells, we analyzed haptokinetic migration (movement of cells
across extracellular matrix (ECM)) in vitro, applying two different
cell migration assays. First we analyzed the effect of La depletion
on migration of cell populations and performed wound-healing
(scratch) assays [28,29]. The ability of SCC 22B cells to migrate
into a ‘‘wound’’ caused by a scratch was quantified by measuring
the remaining open area of the scratch using NIH image after
24 hours (Fig. 3A). These studies demonstrate that La depletion
reduced the repopulation of the wound by about 50% when
compared with control-treated SCC 22B cells (Fig. 3B). Next we
examined cell motility using the single-cell migration track assay.
This assay examines the ability of individual cells to form
migration tracks through a field of fluorescent microspheres
[30]. We plated gfp-positive La-depleted or control-treated SCC
22B cells on fibronectin-coated plates covered with fluorescent
microspheres. The next day, migrating cells were identified as cells
Figure 2. La protein expression promotes proliferation and cell cycle progression of SCC 22B cells. (A) Lower La expression in siRNA-
mediated SCC 22B cells (see Western blot analysis in inlet) correlates with decreased proliferation rate (dotted line). (B) Reduced proliferation rate of
La-depleted SCC 22B cells as determined as mean 6SD (error bars) of 5 independent experiments performed in triplicates. P value,0.01 (two
asterisks). Two-tailed P value was determined by paired t-test applying Prism 4 (GraphPad Software). (C) SiRNA-mediated depletion of La does not
reduce the number of viable cells as determined by counting of trypan blue-negative SCC 22B cells as determined as mean 6SD (error bars) of 3
independent experiments. (D) La depletion (La siRNA) in SCC 22B cells does not induce caspase-3 cleavage of PARP (under apoptosis PARP fragments
into 116 and 85 kDa). Representative Western blot analysis of three independent experiments. As positive control PARP cleavage was induced by UV
light (lane UV). GAPDH was applied as loading control. (E) SiRNA-mediated depletion of La correlates with a G1 cell cycle arrest in SCC 22B cells (P
value,0.05 (one asterisks)). Two-tailed P value was determined by paired t-test applying Prism 4 (GraphPad Software). Error bars represent the mean
6SD of 3 independent experiments. (F) La depletion does not reduce cyclin D1 protein expression in SCC 22B cells. GAPDH was applied as loading
control. Representative Western blot analysis of three independent experiments.
doi:10.1371/journal.pone.0025402.g002
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fluorescence (Fig. 3C). Quantification of our data demonstrated
that siRNA-mediated depletion of La reduces cell migration by
about 65% when compared to control-treated cells (Fig. 3D). The
results from both haptokinetic migration assays demonstrate that
depletion of the RNA-binding protein La inhibits fundamental
processes involved in cell migration of metastasis-derived 22B
SCC cells, which is a so far unknown function for La and supports
the notion that elevated La levels contribute to cell motility in
HNSCC.
To exclude ‘‘off-target’’ effects of the siRNA-mediated La
depletion we performed siRNA rescue experiments. Therefore we
transfected La-depleted 22B SCC cells with gfp-tagged La, which
is resistant to La-specific siRNA due to three silent point mutations
in the La siRNA binding site (gfpLaR) [21]. With these cells we
determine whether the overexpression of siRNA-resistant La
rescues the phenotype of reduced single-cell migration observed in
La-depleted 22B SCC cells (Fig. 4A and B). Indeed, the data
clearly show that the reduced migration of La-siRNA-treated 22B
SCC cells was due to La-specific depletion of La and not due to
unspecific off-target effects.
Depletion of La reduces b-catenin protein expression in
SCC 22B cells
To get insight into the role and function of La in cell motility we
tested the expression of the following factors well known to be
implicated in cell motility: focal adhesion kinase (FAK) [31], b-
catenin[32]andcofilin[33].QuantitativeWesternblot analysisand
normalization to GAPDH revealed that the protein expression of b-
catenin was significantly but only slightly reduced by 30% in La-
depleted SCC 22B cells, whereas FAK and cofilin expression were
unchanged (Fig. 5A and B). To demonstrate that the reduced b-
catenin expression was not caused by siRNA-dependent off-target
effects, we transfected La-depleted SCC 22B cells with the gfpLaR
plasmid to overexpress siRNA-resistant gfpLa in cells in which
endogenous La level were reduced due to La-specific siRNAs. Two
days later we sorted the gfp-positive cells and performed Western
blot analysis demonstrating that the expression of siRNA-resistant
gfpLa protein (gfpLaR) rescues the b-catenin expression in La-
depleted cells (Fig. 5C). This experiment underscores that b-catenin
expression depends on cellular La protein level and is not caused by
siRNA-dependent off-target effects.
Depending on its localization b-catenin plays a dual role within
the cell: (I) in cytoplasmic membranes as part of the adherens
junctions it regulates cell-cell adhesion [34], and (II) after Wnt-
signaling activation b-catenin shuttles into the nucleus and up-
regulates the transcription of tumor promoting target genes
[35,36]. In various types of cancer, including HNSCC, aberrant
activation of b-catenin can promote tumor progression by
positively effecting cell proliferation, differentiation, survival,
adhesion, migration, invasion, and tumor growth in nude mice
[36,37,38,39,40,41,42]. Reduced membranous staining for b-
catenin was observed in less-differentiated oral SCC [43,44] and
increased b-catenin expression in HNSCC patient samples
correlated with higher tumor stage [40,45]. The localization of
b-catenin to the cytoplasmic membrane was unchanged in La-
Figure 3. La supports cell motility of SCC 22B cells. (A) Wound healing assay: La depletion significantly reduces migration of UM-SCC 22B cells
into the denuded area. Phase contrast pictures of the scratched area were taken at time 0 and after 24 hours using a Zeiss Axio Observer microscope
and x10 objective power, and (B) the denuded area was quantified at each time point using NIH image software (AU=arbitrary units). Two-tailed P
value,0.001 (three asterisks) was determined by paired t-test applying Prism 4 (GraphPad Software). Error bars represent the mean 6SD of 3
independent experiments in triplicates. (C) Migration track assay: On a field of fluorescent microspheres gfp-transfected La-depleted and control-
treated SCC 22B cells were seeded at low density (4 cells per mm
2) and non-fluorescent tracks created by gfp-transfected cells were evaluated by
fluorescent microscopy after 24 hours using a Zeiss Axio Observer microscope and x40 objective power. (D) Quantification of cell motility by
counting the number of non-fluorescent tracks of gfp-transfected cells (=migrating cells). La depletion significantly reduces migration of single SCC
22B cells. Two-tailed P value,0.01 (two asterisks) was determined by paired t-test applying Prism 4 (GraphPad Software). Error bars represent the
mean 6SD of 2 independent experiments in triplicates.
doi:10.1371/journal.pone.0025402.g003
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protein level in La-depleted metastasis-derived SCC 22B cells
suggests, that La supports b-catenin expression in metastatic SCC
cells. Since it is known that the RNA-binding protein La stimulates
mRNA translation in cancerous cells [21,22,23] and because cell
migration depends on b-catenin mRNA translation in astrocytes
[38], we speculate that elevated La stimulates b-catenin mRNA
translation directly or stimulates a positive regulator of b-catenin
expression in HNSCC.
La expression promotes SCC 22B cell invasion and MMP-
2 protein expression in vitro
We also were interested to test whether La supports the invasive
potential of metastasis-derived SCC cells. For those experiments
Figure 4. Rescue of reduced cell motility by overexpression of siRNA-resistant gfp-tagged La in La-depleted SCC 22B cells. (A)
Western blot analysis demonstrates overexpression of gfp-tagged, La-siRNA resistant La in La-depleted (gfpLaR) SCC 22B cells. (D) Quantification of
cell motility by counting the number of non-fluorescent tracks of gfp-transfected cells (=migrating cells). La depletion significantly reduces migration
of single SCC 22B cells and can be rescued to levels determined in control-treated cells by overexpression of La-siRNA resistant La. Two-tailed P
value,0.01 (two asterisks) was determined by paired t-test applying Prism 4 (GraphPad Software). Error bars represent the mean 6SD of 2
independent experiments in triplicates.
doi:10.1371/journal.pone.0025402.g004
Figure 5. Reduced b-catenin protein expression in La-depleted SCC 22B cells. (A) Western blot analysis to determine FAK, b-catenin and
cofilin protein expression levels in La-depleted SCC 22B cell extracts. GAPDH was applied as loading control. (B) For quantification of Western blot
experiments chemiluminescent signals were recorded using an ImageQuant ECL systems and quantified using ImageQuant TL software. Two-tailed P
value,0.001 (three asterisks) was determined by paired t-test applying Prism 4 (GraphPad Software). Error bars represent the mean 6SD of 4
independent experiments for b-catenin and 3 independent experiments for FAK and cofilin. (C) Overexpression of siRNA-resistant gfpLa protein
(gfpLaR) rescues b-catenin expression in La-depleted SCC 22B cells. (D) Immunofluorescent staining shows localization of b-catenin within the
cytoplasmic membrane in both La-depleted and control-treated SCC 22B cells.
doi:10.1371/journal.pone.0025402.g005
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ability of control-treated and La-depleted SCC cells to invade and
move through Matrigel-coated transwells. As shown (Fig. 6A), the
potential of La-depleted SCC cells to invade through the
transwells was significantly diminished when compared to the
control-treated cells. These results suggest that La affects both cell
motility and invasiveness of metastasis-derived 22B SCC cells.
The ability of cells to invade requires the expression and activity
of matrix metalloproteinases (MMPs), which are extracellular
endopeptidases known to be key in breaking down barriers formed
by the extracellular matrix [46,47,48]. MMP overexpression can
facilitate tumor cell growth, migration, invasion, and metastasis in
many different types of cancer, including oral cancer [49,50]. In
contrast, some MMPs exert dual functions and are able also to
inhibit tumor progression depending on tumor stage, tumor site,
enzyme localization and substrate, as recently reviewed in Gialeli
et al. [51]. Interestingly, quantitative Western blot analysis
revealed a strong reduction of MMP-2 protein level in La-
depleted cells when compared with control-treated SCC 22B cells
(Fig. 6B and C). Elevated MMP-2 expression in oral SCC
correlates with aggressive oral tumor behavior and poor prognosis
[52,53,54,55] and was suggested as biomarker for early N-stage,
aggressive oral SCC [53].
In summary these experiments illuminate a so far unexpected
role of the RNA-binding protein La in cell motility and invasion.
The finding that La promotes the expression of b-catenin and
MMP-2 underscores an important role of La in tumor progression
of HNSCC.
Materials and Methods
Cell lines, siRNA transfection and siRNA rescue
HNSCC cell line UM-SCC 22B [26] were kindly provided by
Keith Kirkwood (MUSC) and grown in advanced DMEM plus
5% fetal bovine serum. La-specific depletion was performed as
described recently [21], and shortly, by transfecting 2x10
6 SCC
22B cells with 3 mg of La-specific (La siRNA) or control-siRNA
(Con siRNA) using a Nucleofector according to the manufacturer’s
instructions (Nucleofector Kit V, program U-029, AMAXA,
Germany). For gfp co-expression 2 mg of gfp expression plasmid
(AMAXA) was added to the transfection mix. The siRNA
duplexes were designed as 21-mers with 39-dTdT overhangs
[56] and synthesized by Dharmacon RNAi Technologies (USA).
La-siRNAs were directed against the La sequence (NM_003142).
La-siRNA (+): 59-GAAACAGACCUGCUAAUACTT-39 and La-
siRNA (-) 39-TTCUUUGUCUGGACGAUUAUG-59; control-
siRNAs are directed against the Luciferase sequence (referred to as
Con [56]: Con-siRNA (+)5 9-CGUACGCGGAAUACUUC-
GATT-39 and Con-siRNA (-) 39-TTGCAUGCGCCUUAU-
GAAGCU-59. For the rescue experiments applying PCR-based
mutagenesis created the gfpLaR plasmid as described previously
[21]. The following oligonucleotides, which introduce three silent
point mutations (bold and underlined), were used: 59-CCAGAA-
GTACAAAGAAACCGATCTGCTGATACTTTTCAAGG-39,
59-CCTTGAAAAGTATCAGCAGATCGGTTTCTTTGTAC-
TTCTGG-39. For the rescue experiments 2x10
6 La-depleted
SCC 22B cells were transfected with 3 mg of gfpLaR or 2 mgo f
gfp expression plasmid (AMAXA) using a Nucleofector according
to the manufacturer’s instructions (Nucleofector Kit V, program
U-029, AMAXA, Germany). La-depleted, control-treated and La-
rescued SCC 22B cells were analyzed by Western blotting and
single-cell migration track assays 24 hours after transfection.
Immunohistochemistry and immunofluorescence
The immunohistochemical staining was performed as de-
scribed recently [21] by applying the monoclonal human La-
specific 3B9 antibody [200 ng/ml] [24] with a dilution of 1:200
on the oral cavity tissue microarray (TMA, Imgenex Corp.,
IMT-01250). For control staining mouse immunoglobulin
isotype IgG2a,k (eBioscience, [500 ng/ml], dilution 1:200) was
applied on successive SCC tissue sections. For immunofluores-
cence the cells were fixed with 3.7% methanol-free formaldehyde
(Thermo Scientific) for 10 min at room temperature. Afterwards
cells were washed twice with 1x PBS and permeabilized with
0.3% Triton-X 100 in 1x PBS for 10 min at room temperature.
Cells were washed five times with 1x PBS and blocked with horse
serum (ImmPress Reagent Kit, Vector) for 30 min at room
temperature. The anti-b-catenin antibody (#9581, Cell Signal-
ing Technology, dilution 1:200) was applied over night at 4uC
and thereafter washed off five times with 1x PBS. The secondary
antibody (anti-rabbit Rhodamine RedX, Invitrogen, dilution
1:500) was applied for 30 min at room temperature. The cells
were washed five times with 1x PBS and mounted with
Vectashield Mounting Medium for Fluorescence with DAPI
(Vector).
Figure 6. La promotes in vitro invasion and MMP-2 protein expression of SCC 22B cells. (A) In vitro invasion of La-depleted cells is reduced
compared to control-treated SCC 22B cells. Two-tailed P value,0.001 (three asterisks) was determined by paired t-test applying Prism 4 (GraphPad
Software). Error bars represent the mean 6SD of 3 independent experiments. (B) Reduced MMP-2 protein expression in La-depleted SCC 22B cells as
determined by Western blot analysis. (C) For quantification of Western blot experiments chemiluminescent signals were recorded using an
ImageQuant ECL systems and quantified using ImageQuant TL software. Two-tailed P value,0.01 (two asterisks) was determined by paired t-test
applying Prism 4 (GraphPad Software). Error bars represent the mean 6SD of 4 independent experiments.
doi:10.1371/journal.pone.0025402.g006
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and trypan blue exclusion assay
Proliferation rates were determined as described recently by
applying the CyQuant Cell Proliferation Assay Kit (Invitrogen)
[21]. The number of re-attached cells was determined 5 hours
after seeding (FU=fluorescence units). The number of dead cells
was determined by Annexin V and propidium iodide (PI) co-
staining on day 2 after the second siRNA treatment applying the
the Annexin-V-FLUOS Staining Kit (Roche). Annexin V staining
and propidium iodide incorporation was determined by FACS
analysis. For cell cycle analysis, cells were stained with propidium
iodide two days after La-specific (La siRNA) and control (Con
siRNA) siRNA treatment and cell cycle populations were analyzed
by FACS, as described previously [21]. For the trypan blue
exclusion assay trypsinized cells were stained with 0.2% trypan
blue in 1x PBS followed by counting of unstained cells (viable) and
stained cells (nonviable) in a hemocytometer.
Western blot analysis
Cells were lysed and protein was analyzed by SDS-polyacryl-
amide gel electrophoresis (SDS-PAGE). The following antibodies
were applied: monoclonal human La-specific 3B9 antibody [24],
anti-PARP (#H-250, Santa Cruz, dilution 1:2,000), anti-Tubulin,
(#T5168, Sigma, dilution 1:4,000), anti-GAPDH (#25778 Santa
Cruz, dilution 1:2,000), anti-MMP-2 (#4022, Cell Signaling
Technology, dilution 1:1,000), anti-cofilin (#C8736, Sigma,
1:1000), anti-b-catenin (#9581, Cell Signaling Technology,
dilution 1:1,000), anti-FAK (#610087, Cell Signaling Technology,
dilution 1:1,000). Secondary antibodies (dilution 1:20,000) were
horseradish peroxidase-conjugated (Dianova, Germany).
Wound healing assay
Wound healing assay was performed similar as described
previously [29]. Briefly, La-depleted and control-treated UM-SCC
22B cells were allowed to grow to 90% confluence in a 12-well
plate (Costar). The medium was replaced with serum-free medium
and left overnight before scratching a wound using a 200 ml
pipette tip. Phase contrast pictures of the scratched area were
taken at time 0 and after 24 hours exactly at the same position at a
marked area on the cell culture plate using a Zeiss Axio Observer
microscope. The scratched area was quantified at each time point
using NIH image software.
Migration track assay
Wells were pre-coated with 5 mg/ml fibronectin (Fisher) in 1x
PBS for 4 hours at room temperature or overnight at 4uC and
then overlaid with a field of 1 mm in diameter carboxylate-
modified polystyrene fluorescent microspheres (Invitrogen) in 1x
PBS and left to settle for at least 2 hours at 4uC. Thereafter, gfp-
transfected La-depleted and control-treated SCC 22B cells were
seeded at low density (4 cells per mm
2) in normal growth medium
and incubated for a period of 24 hours. Non-fluorescent tracks
created by gfp-transfected cells were then evaluated by fluorescent
microscopy using a Zeiss Axio Observer microscope and
quantified by counting the number of non-fluorescent tracks of
gfp-transfected cells (=migrating cells) on each plate.
Invasion assay
In vitro invasion assays were performed according to the
manufacturer’s instructions (BD BioCoat Matrigel Invasion Cham-
ber) or by coating 24-well Transwell plates (Corning) with 1mg/ml
Matrigel (BD #354230) in 1x PBS. La-depleted or control-treated
SCC 22B cells were plated in triplicates on Matrigel-coated
Transwell inserts at 1610
5 in serum-free DMEM. The lower
chamber contained DMEM with 5% FBS as a chemoattractant.
After 24 hours of incubation, non-migrating cells were removed
from the upper chamber with a cotton swab. According to the
manufacturer’s instructions (Cell Biolabs, colorimetric invasion
assay, #CBA-100-C) cells that had invaded through the Matrigel-
coated membrane to the lower surfacewere fixed, stained, extracted
and quantified by optical density measurement at 560 nm applying
a multiplate reader. Alternatively, cells on the lower surface of the
membrane were fixed and stained according to manufacturer’s
instructions with the Diff-Quick Stain Kit (IMEBINC, #K7128)
followed by mounting and counting cells within 10 random
microscopic fields.
Supporting Information
Figure S1 Control staining for La-specific immunohistochemis-
try in SCC tissue from oral cavity. Human La-specific antibody
(anti-La 3B9) and control staining with mouse immunoglobulin
isotype IgG2a,k (IgG) of successive SCC tissue sections. Scale bar
represents 100 mm.
(TIF)
Figure S2 SiRNA-mediated depletion of La demonstrates that
anti-La 3B9 antibody specifically recognizes the RNA-binding
protein La. Control siRNA- (Con) and La siRNA-treated SCC 22B
cells were grown on glass slides, fixed with 3.7% formaldehyde and
permeabilized with 0.3% Triton-X-100 in 1x PBS. La-specific
brown staining was achieved following the protocol for IHC as
described under MATERIAL/METHODS. Briefly, cells were
blocked with mouse-serum (ImmPress Reagent, Vector), hybridized
with anti-La 3B9 antibody (1:200), incubated with anti-mouse Ig
peroxidase (ImmPress Reagent, Vector) and stained with Im-
mPACT DAB substrate (Vector). Counterstaining was performed
with Hematoxylin QS (Vector). Scale bar represents 200 mm.
(TIF)
Figure S3 Morphological differences between SCC 22B and
HeLa cells. Light microscopic images in low and high density of
SCC 22B cells and HeLa cells purchased from ATCC. Scale bar
represents 200 mm.
(TIF)
Figure S4 Depletion of La does not increase the number of dead
SCC cells. The number of dead cells in La-depleted and control-
treated SCC 22B cells was determined by Annexin V and
propidium iodide (PI) co-staining. Error bars represent the mean
6SD from three independent experiments.
(TIF)
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